Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services. Read more about Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19 Read more about CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19. Read more about A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia Read more about An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection Read more about Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine Read more about Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine Read more about Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine
The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination Read more about The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis Read more about Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above Read more about Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above
